In the most recent Real Talks webinar, “Protecting Margins from Tariff Risks,” Carlos Centurion, River Logic’s President, explored how supply chain leaders can proactively prepare for rising tariffs and their impact on manufacturing and supply chain networks. Many leaders have expressed concerns about effectively assessing operational and financial effects while
Author: Kevin Davidson The Consumer Health Goods industry encompasses products that promote health and well-being, including OTC (Over-The-Counter) medications, nutritional supplements, cosmetics, and personal care products. Operating at the intersection of pharmaceutical and consumer packaged goods (CPG) sectors, this industry combines strict regulatory requirements with consumer-driven dynamics, creating unique network
Author: Carlos Centurion As we reflect on 2024, it’s clear that the landscape of supply chain strategy has been fundamentally reshaped. Disruptions have become the norm—ranging from geopolitical instability, inflation-driven economics, and tariff uncertainties to extreme weather events. While these challenges test even the most robust supply chains, they present
Ash Grove’s Shift: From Traditional Network Design to Value Chain Optimization Author: Carlos Centurion The complexities of modern supply chains demand more than traditional network design approaches. That’s why I had the privilege of sitting down with Jose “Pepe” de la Garza, Vice President of Supply Chain North America at
Author: Carlos Centurion With a potential return to high U.S. import tariffs looming, supply chain leaders face renewed pressure to brace for financial impacts. However, instead of panicking over unknowns or relying on traditional cost-cutting measures, the forward-thinking approach involves modeling “what-if” scenarios prioritizing profitability across the entire value chain.
Author: Nathan Goldstein In the complex and highly regulated world of pharmaceuticals, long-range planning (LRP) plays a crucial role in sustaining growth, profitability, and innovation. It requires a deep understanding of market dynamics and a strategic grasp of the end-to-end operational complexity. One of the most valuable analyses for this
Author: Nathan Goldstein In recent years, the life sciences industry has been drastically impacted by regulatory pressures, complex global networks, and rising production costs. This has forced supply chain leaders to develop aggressive business models that meet both regulatory and market demands while ensuring resilience across all components of their
Author: Eric Uresti Capacity Planning is not just about cutting costs but also driving growth and ensuring supply chain resiliency.